Pro Share Advisors LLC Passage Bio, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.63 - $3.46 $20,463 - $43,436	-12,554 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.66 - $6.49 $8,432 - $20,573	-3,170 Reduced 20.16%	12,554 $38,000
Q4 2021 Feb 08, 2022	SELL	$6.24 - $10.2 $3,644 - $5,956	-584 Reduced 3.58%	15,724 $100,000
Q3 2021 Nov 12, 2021	SELL	$9.73 - $15.52 $29,297 - $46,730	-3,011 Reduced 15.59%	16,308 $162,000
Q2 2021 Aug 13, 2021	BUY	$12.44 - $19.45 $53,753 - $84,043	4,321 Added 28.81%	19,319 $256,000
Q1 2021 May 14, 2021	BUY	$16.24 - $29.83 $39,901 - $73,292	2,457 Added 19.59%	14,998 $262,000
Q4 2020 Feb 09, 2021	BUY	$14.28 - $29.73 $179,085 - $372,843	12,541 New	12,541 $321,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.